Prognostic implication and oncogenic role of DDIT3 in breast cancer
Fajia Yuan , Lirong Jia , Jin Jin , Yuezhen Liu , Xiaojun Cao , Hui Li
Cancer Plus ›› 2026, Vol. 8 ›› Issue (1) : 025100014
Although DNA damage-inducible transcript 3 (DDIT3) has been identified as a novel gene associated with breast cancer, its clinical significance, biological function, and underlying mechanisms remain unclear. By integrating immunohistochemistry with data from The Cancer Genome Atlas (TCGA), we discovered that elevated levels of DDIT3 Messenger RNA and protein expression are significantly associated with poor prognosis in patients with breast cancer. Functional assays and preliminary mechanistic studies reveal that DDIT3 may promote breast cancer cell proliferation and metastasis, potentially by downregulating activating transcription factor-2.
Breast cancer / DDIT3 / Prognosis / Oncogene
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
Chinese Society of Clinical Oncology, Experts Committee on Breast Cancer, China Anti-Cancer Association, the Society of Breast Cancer, Chinese Medical Association, Chinese Society of Breast Surgery. [Expert consensus on the diagnosis and treatment of young breast cancer in China (2022 Edition)]. Zhonghua Yi Xue Za Zhi. 2023; 103(6):387-403. doi: 10.3760/cma.j.cn112137-20220907-01895 |
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
/
| 〈 |
|
〉 |